Phenylketonurias Clinical Trial
Official title:
Nutrition Status of Adults With Phenylketonuria Treated With Pegvaliase
Verified date | March 2021 |
Source | Boston Children's Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Conduct a cross-sectional analysis of the nutritional status of individuals with PKU treated with pegvaliase for one or more years or who have followed an unrestricted diet for 6 or more months while on pegvaliase treatment. We will evaluate laboratory markers of nutritional status, including markers of protein and micronutrient nutriture. In addition, a three-day food record and food frequency questionnaire will be obtained to assess protein intake and overall diet quality.
Status | Completed |
Enrollment | 18 |
Est. completion date | December 31, 2020 |
Est. primary completion date | December 31, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: 1. Diagnosis of phenylketonuria 2. Aged 18-65 years 3. Currently treated with pegvaliase 4. Have either 1) received treatment with pegvaliase for one or more years or 2) followed an unrestricted diet for 6 or more months while on pegvaliase 5. Currently following an unrestricted diet that meets or exceeds the RDA for protein (0.8 g/kg/day) Exclusion Criteria: 1. Unable to consent to study 2. Under age 18 years or over age 65 3. Routine food intake provides less than the RDA for protein (0.8 g/kg/d) 4. Consuming any PKU medical foods |
Country | Name | City | State |
---|---|---|---|
United States | Boston Children's Hospital | Boston | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Boston Children's Hospital | BioMarin Pharmaceutical |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mean concentrations of serum marker(s) of protein status | through study completion, an average of 1 year | ||
Primary | Mean concentrations of serum marker(s) of micronutrient status | through study completion, an average of 1 year | ||
Primary | Mean concentrations of serum marker(s) of essential fatty acid status | through study completion, an average of 1 year | ||
Primary | Mean concentrations of serum marker(s) of cardiovascular status | through study completion, an average of 1 year | ||
Primary | Mean protein intake (g/day) as reported on a three-day food record | through study completion, an average of 1 year | ||
Primary | Mean micronutrient intake (%DRI) as reported on a three-day food record | through study completion, an average of 1 year | ||
Secondary | Mean Healthy Eating Index-2015 scores calculated from the Diet History Questionnaire III | "The Healthy Eating Index-2015 (HEI-2015) is… used to assess how well a set of foods aligns with the 2015-2020 Dietary Guidelines for Americans. The HEI-2015 includes 13 components that can be summed to a maximum total score of 100 points. The components capture… adequacy components and… moderation components. For the adequacy components, higher scores reflect higher intakes that meet or exceed the standards. For the moderation components, higher scores reflect lower intakes because lower intakes are more desirable. A higher total score indicates a diet that aligns better with the Dietary Guidelines." - https://www.cnpp.usda.gov/sites/default/files/healthy_eating_index/HEI2015-ScoresForAmericans.pdf
Adequacy components include total fruits, whole fruits, total vegetables, greens and beans, whole grains, dairy, total protein foods, seafood and plant proteins, fatty acids. Moderation components include refined grains, sodium, added sugars, and saturated fats. |
through study completion, an average of 1 year | |
Secondary | Correlation between serum micronutrient concentrations and average micronutrient intake | through study completion, an average of 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05998109 -
PheCheck Feasibility Study
|
||
Not yet recruiting |
NCT04433728 -
Life With Phenylketonuria. Adult Neurological Outcome of PCU Screened Patients From 1971 to 2002.
|
||
Completed |
NCT01209819 -
Bone Mineral Density in Adults With Hyperphenylalaninemia
|
N/A | |
Active, not recruiting |
NCT05174559 -
Additional Dietary Large Neutral Amino Acids (LNAA) for Improved Symptoms in Adult Classical Phenylktonuria (PKU)
|
N/A | |
Not yet recruiting |
NCT04969809 -
Comparison of Atherogenic Risk Factors and Efficacy of Nutritional Treatment Among Adult Phenylketonuria Patients
|
N/A | |
Recruiting |
NCT04404530 -
Nutritional Impacts of Palynziq on Patients With Phenylketonuria (PKU)
|
||
Recruiting |
NCT05827536 -
Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus SoC in Patients With PKU.
|
N/A | |
Active, not recruiting |
NCT05971563 -
Amino Acid Kinetics of GMP-AA in Healthy Human Volunteers
|
N/A | |
Enrolling by invitation |
NCT03655223 -
Early Check: Expanded Screening in Newborns
|
||
Completed |
NCT04368624 -
PKU Skin Stripping
|
||
Completed |
NCT04452513 -
A Prospective Clinical Study of Phenylketonuria (PKU)
|
||
Completed |
NCT05497050 -
The Effect of Nursing Empowerment Program
|
N/A | |
Completed |
NCT04943393 -
Remote Neurocognitive and Psychological Assessment in PKU
|
||
Completed |
NCT05096988 -
Evaluation of PKU Sphere Liquid
|
N/A | |
Not yet recruiting |
NCT06332807 -
AAV Gene Therapy Clinical Study in Adult Classic PKU
|
Phase 1/Phase 2 | |
Completed |
NCT00225615 -
A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels
|
Phase 3 | |
Recruiting |
NCT05128149 -
Metabolic Control and Patient Well-being in Phenylketonuria: do Guidelines Make a Difference?
|
||
Terminated |
NCT05229549 -
Study to Evaluate the Effect on Nitrogen Retention of Two Different Posology Schemes of PKU GOLIKE PLUS 3-16 and Free AAs in Patients With Phenylketonuria
|
N/A | |
Enrolling by invitation |
NCT05356377 -
Preliminary Study of Brain Effects of Palynziq-Related Changes in Phenylalanine in Individuals With PKU
|
||
Not yet recruiting |
NCT06337864 -
Evaluating the Efficacy and Safety of Large Neutral Amino Acids in the Treatment of Classical Phenylketonuria
|
N/A |